2 active
/
5 total (since 2015)
0
Phase 1 Active
0 total
0
Phase 2 Active
2 total
2
Phase 3 Active
3 total
0
Phase 4 Active
0 total
Top Sponsors (Industry)
Sorted by active Active Done Failed
Zogenix, Inc. 1 0 0
Immedica Pharma AB 1 0 0
NCT05064878 ACTIVE NOT RECRUITING
A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder
Zogenix, Inc. n=87
NCT05249556 NOT YET RECRUITING
Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
Immedica Pharma AB n=20
NCT03572933 COMPLETED
Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder
Marinus Pharmaceuticals n=101
Data: ClinicalTrials.gov